These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2567613)

  • 1. R-R interval during neuroleptic treatment.
    Motomura N; Asaba H; Sakai T
    Biol Psychiatry; 1989 Jun; 26(2):219-20. PubMed ID: 2567613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 3. Certain neuroleptics reduce bone mineralization in schizophrenic patients.
    Higuchi T; Komoda T; Sugishita M; Yamazaki J; Miura M; Sakagishi Y; Yamauchi T
    Neuropsychobiology; 1987; 18(4):185-8. PubMed ID: 2900482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of malignant neuroleptic syndrome. Anatomoclinical study].
    Stroia L; Alexianu M; Popa G; Rişca E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1983; 28(1):47-52. PubMed ID: 6137052
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant hyperthermia caused by neuroleptics].
    Escolano Villén F; Aguilar Sánchez JL; Castrillo Ferrando A; Beser Gascón P; Sabaté Pes A; Campos Suárez JM; Villar Landeira JM
    Rev Esp Anestesiol Reanim; 1985; 32(4):189-91. PubMed ID: 2864723
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cognition disorders in the course of treatment with neuroleptics].
    Puzyński S; Jakubik A; Kalinowski A
    Psychiatr Pol; 1973; 7(4):453-9. PubMed ID: 4149519
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent sinus arrest in association with neuroleptic malignant syndrome.
    Parry AK; Ormerod LP; Hamlin GW; Saleem PT
    Br J Psychiatry; 1994 May; 164(5):689-91. PubMed ID: 7921725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
    Gallien M; Schnetzler JP; Morin J
    Ann Med Psychol (Paris); 1975 Feb; 1(2):237-48. PubMed ID: 9021
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of deep vein thrombosis associated with antipsychotic drug use.
    Matsumoto M; Konno T; Tamba K; Abe T; Kato S; Kajii E
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):450-1. PubMed ID: 15298663
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sensory disorders arising during neuroleptic therapy].
    Rovinskaia SA; Revva LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):905-9. PubMed ID: 6106339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol versus chlorpromazine for schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004278. PubMed ID: 18254045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics.
    Bloom D; Krishnan B; Thavundayil JX; Lal S
    Acta Psychiatr Scand; 1993 Mar; 87(3):223-4. PubMed ID: 8096668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol.
    Smith M; de Souza MA; Pugliese S; Mari Jde J
    Am J Med Genet; 1996 Apr; 67(2):238. PubMed ID: 8723058
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia.
    Higashima M; Takeda T; Nagasawa T; Hirao N; Oka T; Nakamura M; Kitamura M; Koshino Y
    Eur Psychiatry; 2004 Sep; 19(6):380-1. PubMed ID: 15363480
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Meibach RC
    Neurology; 2000 Oct; 55(7):1069. PubMed ID: 11061283
    [No Abstract]   [Full Text] [Related]  

  • 18. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
    Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G
    J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Priapism in neuroleptic therapy].
    Eikmeier G
    Nervenarzt; 1987 Dec; 58(12):771-2. PubMed ID: 3431614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of malignant neuroleptic syndrome. Case report].
    Martius P; Hüther R; Zilker T
    Nervenarzt; 1996 May; 67(5):418-21. PubMed ID: 9005355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.